Concerns rose about prescription medicine safety after FDA inspectors at a South Korean factory supplying the United States found a logbook with pages cut out.
Here's what to know
The National News Desk reported that federal inspection records detailed the missing pages and other findings. Company leaders had directed employees to leave testing information out of official records, and inspectors found that security-camera timestamps had been altered.
Former FDA inspector Peter Baker said he encountered similar conduct "all the time" during his years monitoring drug factories abroad.
"When you're fabricating those records, it represents a serious concern for patient safety," Baker said.
An investigation also revealed that an Indian manufacturer processed raw materials into ingredients for U.S.-bound drugs without first verifying their identities.
Inspectors found that the company had deliberately given the materials false labels to avoid a licensing requirement. Per an FDA report, one of the materials was highly toxic and linked to deadly poisonings worldwide.
More background
Millions of Americans take generic prescription medicines daily, and India supplies close to half of the country's drugs, according to The National News Desk.
It uncovered contaminated manufacturing sites and dangerous errors in drug production as well as destroyed records and falsified testing results.
FDA inspection reports revealed equipment that had not been adequately cleaned for over 27 years. Inspectors also found workers in production areas wearing sandals that exposed their toes along with unidentified residue and rust on surfaces that came into contact with products.
The investigation tracked recalls involving eye drops, children's ibuprofen, heart medication, and drugs that help prevent organ transplant recipients from rejecting their new organs.
What's being done?
The Senate Committee on Aging asked the Government Accountability Office in September to examine whether overseas drug manufacturing was linked to recalls.
Baker has appeared before Congress to advocate broad changes focused on transparency and accountability.
"Without clear consequences for these actions, what incentive is there to really change?" he asked.
The investigative team said it was in contact with committee Chairman Rick Scott and planned to share the GAO report.
It also encouraged people who experienced problems involving improperly made generic drugs to contact reporters Lisa Fletcher at lfletcher@sbgtv.com or Andrea Nejman at anejman@sbgtv.com.
"If it's due to industry pushback, then we've got to change that paradigm because patients come first. Safety comes first. Public health comes first," Baker said, per The National News Desk.
Where can I learn more?
Drug recalls and mislabeled health products show why reliable testing and accurate ingredient records matter.
• A blood pressure medication recall expanded after more chlorthalidone pills failed to dissolve.
• Three wellness injectables were recalled nationwide over endotoxin risk, which can cause shock and death.
• Amazon recalled nearly 113,000 acetaminophen bottles after concerns emerged over discolored tablets inside.
• Wired tested New York bodega peptides, and none contained the labeled active ingredient.
• Utah linked four deaths to supplements sold as kratom-free, then found Schedule I compounds.
Get TCD's free newsletters for easy tips, smart advice, and a chance to earn $5,000 toward home upgrades. To see more stories like this one, change your Google preferences here.







